The Center for Psychedelic Research is recreating real life scenarios to better understand how drugs and alcohol affect the ...

Researchers used EEG to study high-dose inhaled 5-MeO-DMT in humans. Unlike other psychedelics, the drug reduced brain ...

Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...

GH Research’s stock rallied after saying the FDA lifted a hold on its experimental depression treatment.

A new review criticizes current methods of measuring the acute subjective effects of psychedelics. Experts call for the development of new, more comprehensive measures that can accurately assess ...

Psychedelic therapy, involving substances like psilocybin (found in magic mushrooms), MDMA, and ketamine, is gaining recognition as a groundbreaking approach to treating mental health conditions, ...

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of ...

The future of psychedelic research was dealt its biggest setback in years after the FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD) earlier this month, ...

Biotech company MindMed is shoring up its cash stockpile to inch its psychedelic therapies towards approval after the feds’ recent thumbs-down of using MDMA to treat post-traumatic stress disorder.

From magic mushrooms to peyote, psychedelics have made a name for themselves in recent years as potential therapeutics for a range of different conditions, including post-traumatic stress disorder, ...

Governor Phil Murphy signed into law Senate Bill No. 2283 (2R), establishing the Psilocybin Behavioral Health Access and ...